Provided by Tiger Trade Technology Pte. Ltd.

Azenta

36.00
+0.11000.31%
Post-market: 36.520.5200+1.44%16:53 EDT
Volume:1.12M
Turnover:39.92M
Market Cap:1.58B
PE:-13.38
High:36.19
Open:35.74
Low:34.93
Close:35.89
52wk High:46.41
52wk Low:15.93
Shares:43.76M
Float Shares:38.55M
Volume Ratio:0.51
T/O Rate:2.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6900
EPS(LYR):-1.2190
ROE:-7.04%
ROA:-0.73%
PB:1.04
PE(LYR):-29.53

Loading ...

Azenta Restructures Multiomics Segment With Lab Closures

TIPRANKS
·
Oct 07

Azenta Restructures Multiomics Unit, to Close Three North American Labs

Reuters
·
Oct 07

Azenta - Expects to Recognize Charges in FY Ending Sept 30, 2027 and Complete Actions by March 31, 2027 - SEC Filing

THOMSON REUTERS
·
Oct 07

Azenta - Approves Restructuring Plan Within Multiomics Segment on October 5, 2026 - SEC Filing

THOMSON REUTERS
·
Oct 07

Azenta - Estimates Aggregate Pre-Tax Charges of $11 Mln-$13 Mln from Plan - SEC Filing

THOMSON REUTERS
·
Oct 07

Azenta - Plan Includes Workforce Reductions and Closure of Three Multiomics Lab Sites in North America - SEC Filing

THOMSON REUTERS
·
Oct 07

Azenta Price Target Maintained with a $37.00/Share by Needham

Dow Jones
·
Sep 14

Brooks Automation Holdings, Inc. Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

THOMSON REUTERS
·
Sep 10

Azenta Files Form 3 for VP, Chief Accounting Officer Erik J. Bello

Reuters
·
Sep 10

Azenta Completes B Medical Divestiture With Loan Repayment

TIPRANKS
·
Sep 04

Azenta Receives Early Repayment of $35 Million Secured Vendor Loan

Reuters
·
Sep 04

Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems

THOMSON REUTERS
·
Sep 04

How Investors Are Reacting To Azenta (AZTA) CEO Resignation And Interim Leadership Change

Simply Wall St.
·
Aug 26

U.S. Small Caps Close Lower; Azenta Falls Furthest

Dow Jones
·
Aug 25

Top Midday Decliners

MT Newswires Live
·
Aug 25

Azenta Shares Fall on $3M Charge, CEO Exit

Dow Jones
·
Aug 25

U.S. Stocks on the MOVE-Azenta, Qiagen NV, Capricor Therapeutics

Reuters
·
Aug 24

Azenta Names Martin Madaus Interim CEO as John Marotta Resigns

Reuters
·
Aug 24

Azenta, - Expects Q4 Fiscal 2026 Adj Ebitda Impacted by $3 Mln One-Time Consulting Expense

THOMSON REUTERS
·
Aug 24

Azenta, - Reaffirms Q4 Fiscal 2026 Total Revenue Guidance

THOMSON REUTERS
·
Aug 24